RxDoctor Payments Data

Rita Greene

Primary Care · Maricopa, AZNPI 1235517244

Payments from drug & device makers

$572in general payments, 2019–2025

Across 28 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$81
  • Sumitomo Pharma America, Inc.$77
  • Lilly USA, LLC$66
  • Amgen$39
  • Insulet Corporation$39
  • Procept Biorobotics Corporation$38
  • plus $233 from 11 others

What the payments were for

  • Speaking & faculty fees$244%
  • Food & beverage$54896%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$572 in reported general payments places this provider in the 50th percentile of 151 primary care providers in Arizona.

See all primary care providers in Arizona

Medicare billing

Part B allowed, 2024
$66,399
Medicare patients
457
Services billed
19,558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron66$42,339
MyrbetriqMirabegron49$36,509
EliquisApixaban13$11,374
Estradiol70$4,231
Solifenacin Succinate50$4,101
Tamsulosin Hcl228$2,854
Trospium Chloride ErTrospium Chloride11$2,182
Testosterone15$1,639
Tolterodine Tartrate ErTolterodine Tartrate21$1,553
Testosterone Cypionate29$1,190
Oxybutynin Chloride ErOxybutynin Chloride30$954
Cefdinir62$940
Atorvastatin Calcium76$870
Silodosin16$734
Finasteride67$684

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$77$42,33966 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 151 primary care providers in Arizona.

Other primary care in Maricopa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →